LEUKOTRIENE-B4 AND TUMOR-NECROSIS-FACTOR RELEASE FROM LEUKOCYTES - EFFECT OF PERITONEAL DIALYSATE

被引:70
作者
JORRES, A
JORRES, D
GAHL, GM
KESSEL, M
MULLER, C
KOTTGEN, E
SERKE, S
SCHULZ, E
MAHIOUT, A
机构
来源
NEPHRON | 1991年 / 58卷 / 03期
关键词
PERITONEAL DIALYSATES; TUMOR NECROSIS FACTOR; LEUKOTRIENE-B4; ENDOTOXIN;
D O I
10.1159/000186436
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The effect of peritoneal dialysate on the capacity of peripheral blood polymorphonuclear (PMNL) and mononuclear leukocytes (MNC) to release leukotriene B4 (LTB4) and tumor necrosis factor alpha (TNF-alpha) was investigated in vitro. Following density gradient separation, aliquots of 5 x 10(6) PMNL or MNC were incubated in peritoneal dialysis fluid containing 1.5% glucose or Hanks' buffer (= control) for 1-2 h at 37-degrees-C. TNF-alpha and LTB4 production was stimulated with Escherichia coli lipopolysaccharide (LPS) and calcium ionophore A23187, respectively. MNC incubated in buffer and LPS produced (mean +/- SD) 1,006 +/- 522 pg TNF-alpha/5 x 10(6) cells; no significant amounts of TNF-alpha were detectable in the presence of dialysate. An inhibition of TNF-alpha release was also observed in MNC exposed to bicarbonate-buffered dialysates (pH 7.40) and 4.25% and 1.5% glucose solution with physiologic osmolality. Incubation of PMNL in Hanks' buffer followed by A23187 stimulation led to production of 29.1 +/- 19.2 ng LTB4/5 x 10(6) cells, whereas glucose-incubated cells were refractory to ionophore stimulation (< 0.1 ng LTB4/5 x 10(6) cells). The failure of dialysate-exposed leukocytes to release inflammatory mediators in response to adequate stimuli may contribute to the impairment of cellular host defense in the setting of continuous ambulatory peritoneal dialysis.
引用
收藏
页码:276 / 282
页数:7
相关论文
共 18 条
[1]  
Alobaidi H M, 1986, Nephrol Dial Transplant, V1, P16
[2]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[3]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[4]   ULTRAFILTRATION TO REJECT HUMAN INTERLEUKIN-1-INDUCING SUBSTANCES DERIVED FROM BACTERIAL CULTURES [J].
DINARELLO, CA ;
LONNEMANN, G ;
MAXWELL, R ;
SHALDON, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (07) :1233-1238
[5]   EFFECTS OF THE COMPOSITION OF PERITONEAL-DIALYSIS FLUID ON CHEMI-LUMINESCENCE, PHAGOCYTOSIS, AND BACTERICIDAL ACTIVITY INVITRO [J].
DUWE, AK ;
VAS, SI ;
WEATHERHEAD, JW .
INFECTION AND IMMUNITY, 1981, 33 (01) :130-135
[6]  
ELIAS JA, 1987, J IMMUNOL, V138, P3812
[7]   CYTOTOXICITY OF COMMERCIAL PERITONEAL-DIALYSIS SOLUTIONS TOWARDS PERITONEAL-CELLS OF CHRONICALLY UREMIC MICE [J].
GALLIMORE, B ;
GAGNON, RF ;
STEVENSON, MM .
NEPHRON, 1986, 43 (04) :283-289
[8]   ANALYSIS OF PERITONEAL-MACROPHAGES IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS [J].
GOLDSTEIN, CS ;
BOMALASKI, JS ;
ZURIER, RB ;
NEILSON, EG ;
DOUGLAS, SD .
KIDNEY INTERNATIONAL, 1984, 26 (05) :733-740
[9]   SUPPRESSION OF NEUTROPHIL SUPEROXIDE PRODUCTION BY CONVENTIONAL PERITONEAL-DIALYSIS SOLUTION [J].
ING, BL ;
GUPTA, DK ;
NAWAB, ZM ;
ZHOU, FQ ;
RAHMAN, MA ;
DAUGIRDAS, JT .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1988, 11 (05) :351-354
[10]   POTENTIAL ROLE FOR INTERLEUKIN-1 IN FIBROSIS ASSOCIATED WITH CHRONIC AMBULATORY PERITONEAL-DIALYSIS [J].
KRANE, SM ;
GOLDRING, MB .
BLOOD PURIFICATION, 1988, 6 (03) :173-177